ARCHIVES

Duke University Suspends Two Clinical Trials After Journal Paper Questions Assay Validity

This article is from The Cancer Letter archive.

Vol. 35 No. 37 | October 9, 2009

Download PDF Visit The Full Archive

Related Articles

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

April 16, 2010

FDA Offers Grants For Conferences

May 1, 1987

Wistar Investigators Report Oncogene Relation to Burkitt’s

November 26, 1982

In Brief: ACCC Annual Meeting Scheduled March 16-19; Lao to Head Pharmacology At Pittsburgh

January 1, 1988

Bypass Budget Going to White House Next Month Will Seek Optimal Funding for Cancer Program

August 22, 1980

BRAF Mutation Testing Classifies Indeterminate FNA Samples

March 29, 2013